149 related articles for article (PubMed ID: 36930525)
21. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
[TBL] [Abstract][Full Text] [Related]
22. The role of prophylactic parathyroidectomy during thyroidectomy for MTC in patients with MEN2A syndrome.
Kavazis C; Romanidis K; Pitiakoudis M; Kesisoglou I; Laskou S; Sapalidis K
Folia Med (Plovdiv); 2023 Oct; 65(5):720-727. PubMed ID: 38351753
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis].
Fang X; Wang H; Dong F; Lian B; Li F; Jin H; Yu Y; Zhang N; Qi X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Sep; 39(9):938-943. PubMed ID: 36082561
[TBL] [Abstract][Full Text] [Related]
24. MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives.
Amodru V; Taieb D; Guerin C; Romanet P; Paladino N; Brue T; Cuny T; Barlier A; Sebag F; Castinetti F
Endocrine; 2020 Sep; 69(3):496-503. PubMed ID: 32388798
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
[TBL] [Abstract][Full Text] [Related]
26. [Multiple endocrine neoplasia type 2A in a family].
Hircsu I; Gazdag A; Bodor M; Berta E; Andrási M; Kanyári Z; Győry F; Barna S; Bhattoa HP; Nagy B; Nagy VE; Erdei A
Orv Hetil; 2020 Jan; 161(2):75-79. PubMed ID: 31902232
[TBL] [Abstract][Full Text] [Related]
27. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
28. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
Thosani S; Ayala-Ramirez M; Palmer L; Hu MI; Rich T; Gagel RF; Cote G; Waguespack SG; Habra MA; Jimenez C
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1813-9. PubMed ID: 24030942
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report.
Li Y; Tan YQ; Tang ZX; Liao QH; Guo ZQ; Lai KB; Wang R; Chen YH
Medicine (Baltimore); 2021 Jun; 100(22):e26230. PubMed ID: 34087905
[TBL] [Abstract][Full Text] [Related]
32. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation in multiple endocrine neoplasia type 2.
Raue F; Frank-Raue K
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):69-75. PubMed ID: 22584709
[TBL] [Abstract][Full Text] [Related]
34. Accelerated MEN2A in homozygous RET carriers in the context of consanguinity.
Machens A; Dralle H
Eur J Endocrinol; 2024 Mar; 190(3):K43-K46. PubMed ID: 38465999
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
36. Multiple endocrine neoplasia type 2A: case report.
Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
[TBL] [Abstract][Full Text] [Related]
37. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
38. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.
Schulte KM; Machens A; Fugazzola L; McGregor A; Diaz-Cano S; Izatt L; Aylwin S; Talat N; Beck-Peccoz P; Dralle H
J Clin Endocrinol Metab; 2010 Sep; 95(9):E92-7. PubMed ID: 20554711
[TBL] [Abstract][Full Text] [Related]
39. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
[TBL] [Abstract][Full Text] [Related]
40. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
